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Protein homeostasis describes the tight supervision of protein synthesis, correct protein maturation and folding, as
well as the timely disposal of unwanted and damaged proteins by the ubiquitin-proteasome pathway or the
lysosome-autophagy route. The cellular processes involved in preservation of protein homeostasis are collectively
called proteostasis. Dysregulation of proteostasis is an emerging common pathomechanism for chronic lung diseases
in the adult and aged patient. There is also rising evidence that impairment of protein homeostasis contributes
to early sporadic disease onset in pediatric lung diseases beyond the well-known hereditary proteostasis disorders such
as cystic fibrosis and alpha-1 antitrypsin (AAT) deficiency. Identifying the pathways that contribute to impaired
proteostasis will provide new avenues for therapeutic interference with the pathogenesis of chronic lung diseases
in the young and adult. Here, we introduce the concept of proteostasis and summarize available evidence on
dysregulation of proteostasis pathways in pediatric and adult chronic lung diseases.
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Maintenance of a functional proteome and protein inter-
action network is essential for the survival of cells and or-
ganisms [1]. The cellular processes involved in preservation
of this protein homeostasis are collectively called proteosta-
sis. It covers all steps in the life of a protein, i.e., protein
synthesis, correct protein maturation and folding, as well
as the timely disposal of unwanted and damaged proteins
by the ubiquitin-proteasome pathway or the lysosome-
autophagy route (Figure 1). Dysfunctional proteostasis is
emerging as a key and common pathomechanism for
chronic lung diseases [2]. The range of lung disorders in
which aberrant protein homeostasis has been implicated
covers both pediatric and adult lung diseases that occur
due to genetic, environmental, or idiopathic causes. The
list includes chronic obstructive pulmonary disease
(COPD) due to cigarette smoking or alpha-1 antitrypsin
(AAT) deficiency, cystic fibrosis, idiopathic pulmonary fi-
brosis (IPF), pulmonary arterial hypertension (PAH), and
some allergic airways diseases. Identifying the pathways of
impaired proteostasis is central to interfere with the* Correspondence: silke.meiners@helmholtz-muenchen.de
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reproduction in any medium, provided the origpathogenesis of chronic lung diseases in the young and
adult [3].Review
Protein synthesis, folding, and function
Proteins are synthesized at the ribosome as a linear se-
quence of amino acids and fold into a complex three-
dimensional structure that enables protein function [4].
Protein folding is usually coupled directly to protein
translation but also takes place in subcellular compart-
ments, such as the endoplasmic reticulum (ER) or mito-
chondria, and involves support by molecular chaperones,
i.e., heat shock proteins (HSP) [5]. Molecular chaperones
also regulate protein localization and protein-protein
interactions, thereby contributing to functional protein
networks [5]. Stress-induced protein modifications, lack
of oligomeric assembly partners, or denaturation results
in protein misfolding and challenges protein folding ener-
getics and the cellular chaperone network [6]. Misfolded
proteins expose hydrophobic surfaces that may trap other
proteins to form protein aggregates, a process called
proteotoxicity [6]. Molecular chaperones prevent protein
aggregation by binding to these hydrophobic residues,
thereby facilitating correct folding in an ATP-dependent
manner [5]. Ensuring proper protein folding by molecular
chaperone networks thus represents the first level of
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Figure 1 (See legend on next page.)
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Figure 1 Life and death of proteins. Proteins are synthesized as a linear amino acid chain at the ribosomes and fold into their native structure
with the assistance of chaperones. Misfolded proteins in the cytosol or in cellular compartments, such as ER and mitochondria, are recognized by
chaperones which support their refolding into the native structure. If misfolded proteins cannot be properly refolded, they are targeted for degradation
mainly by the ubiquitin-proteasome system. For proteasomal degradation, proteins are tagged with a polyubiquitin chain and subsequently
degraded by the proteasome into small peptides. Misfolded proteins of the ER or at the mitochondria are retro-translocated into the cytosol
and transported to the proteasome for degradation with the help of VCP/p97. Aggregated proteins are engulfed by the autophagosome and
degraded after fusion of lysosomes with the autophagosome. Degradation products of the proteasome and the autophagy pathway are mainly
recycled as amino acids for protein synthesis.
Meiners and Ballweg Molecular and Cellular Pediatrics 2014, 1:11 Page 3 of 8
http://www.molcellped.com/content/1/1/11chaperones are unable to successfully restore three-
dimensional protein structure, misfolded proteins are tar-
geted for proteasomal degradation with the help of spe-
cific protein quality ubiquitin ligases [7]. Insoluble protein
aggregates are disposed by autophagy (Figure 1).
Protein degradation by the ubiquitin-proteasome or
autophagy pathways
The ubiquitin-proteasome and the lysosomal autophagy
pathways are the two main protein disposal systems in
the cell. They perform not only housekeeping tasks of
normal protein turnover but also protein quality control
functions that ensure rapid disposal of misfolded and ag-
gregated proteins.
The autophagy pathway comprises sequestration of
cytoplasmic cargo in autophagic vesicles and subsequent
degradation in the lysosome. Three different forms of
autophagy can be distinguished: chaperone-mediated
autophagy in which specific proteins are identified by
chaperones and delivered directly to the lysosome,
microautophagy which describes internalization of cyto-
plasmic contents by the lysosome, and macroautophagy
for unspecific vesicle-mediated degradation via the lyso-
some [8]. Macroautophagy, often referred to simply as
autophagy, allows disposal not only of bulky protein ag-
gregates but also of dysfunctional organelles or parts
thereof. For autophagy, the cargo is sequestered inside a
double-membrane vesicle forming an autophagosome
which then fuses with lysosomal vesicles to form the
autolysosomes where the captured material is degraded
by acid hydrolases [8]. Degradation products such as
free amino and fatty acids are recycled, thereby consti-
tuting the prosurvival function of autophagy, e.g., in re-
sponse to starvation [8]. On the molecular level, more
than 30 autophagy-related genes (ATG) execute all au-
tophagy steps [8]. Impaired nutrient supply as well as
multiple forms of cellular stress induce autophagy by
regulating expression and activation of ATG [9]. More-
over, autophagy also contributes to innate and adaptive
immune surveillance and regulation of host/pathogen
responses [10].
Degradation of specific cellular proteins is mainly
taken over by the ubiquitin-proteasome system. Speci-
ficity of protein degradation is achieved by tagging ofdegradation-prone proteins with polyubiquitin chains.
Polyubiquitination can occur at different lysine residues
of the ubiquitin molecules. Differentially linked ubiquitin
chains have distinct cellular effects: Lysine (K)48-linked
polyubiquitin chains, for example, target proteins for pro-
teasomal degradation while K63 linkages are mainly asso-
ciated with sorting of proteins for lysosomal degradation
pathways [11]. Ubiquitination proceeds along an en-
zymatic cascade, in which ubiquitin is first activated by
the ubiquitin-activating enzyme E1, conjugated by an
E2 ubiquitin-conjugating enzyme, and finally cova-
lently linked to the substrate by a specific E3 ubiquitin
ligase [11,12]. Binding of further ubiquitin molecules
to the previous one enables formation of a polyubiqui-
tin chain which mediates degradation while modifica-
tion of proteins with only one ubiquitin molecule
mediates signaling [11]. Specific regulation of substrate
turnover thus takes place on the level of ubiquitin-
conjugating E3 ligases or - as a newly emerging theme - on
the level of specific deubiquitinating enzymes, so-called
DUBs [13]. The 26S proteasome is the proteolytic unit of
the ubiquitin-proteasome system and specifically degrades
polyubiquitinated proteins. It is composed of one barrel-
shaped 20S catalytic core and one or two cap-like 19S
regulatory complexes. While the 19S regulators facilitate
binding and deubiquitination, as well as ATP-dependent
unfolding of substrates, the 20S proteasome core particle
hydrolyzes proteins with the help of three proteolytic ac-
tive sites into small peptides. The three active sites of the
proteasome have different cleavage specificities with β1
preferably cleaving after acid residues, β2 after basic resi-
dues, and β5 after hydrophobic residues. The active sites
are therefore also named caspase-like, trypsin-like, and
chymotrypsin-like active sites, respectively [12]. In im-
mune cells or upon stimulation with interferon-γ, the
three standard active subunits are exchanged by inducible
subunits to form the immunoproteasome. Degradation
products of the proteasome are not only used for recycling
of amino acids but also exploited for major histocom-
patibility complex (MHC) class I antigen presentation
to define the ? cell's self ? towards the immune system
[14]. The controlled degradation of cellular proteins is
essential for cellular growth, signaling, transcription,
immune responses, and protein quality control and places
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sis [15,16].
Organelle-specific proteostasis
Dysfunctional proteins arise in all cellular compartments
such as the plasma membrane, cytosol, nucleus, ER, and
mitochondria (Figure 1). Misfolded nuclear proteins are
degraded by nuclear proteasomes or via nucleophagy [17].
In contrast, as the ER and mitochondria are not accessible
for the proteasome, specialized pathways compensate for
degradation of misfolded proteins in these compartments.
With nearly one third of all proteins being secreted via the
ER and requiring complex folding and glycosylation, this
organelle is equipped with specialized ER-resident chaper-
ones which recognize misfolded proteins and facilitate
their ubiquitination by ER-associated ubiquitin ligases and
subsequent transport into the cytosol for ubiquitin-
mediated proteasomal degradation. This process is
dependent on the AAA ATPase VCP/p97 and is termed
ER-associated degradation pathway (ERAD) [18]. A simi-
lar pathway exists for mitochondrial proteins, i.e.,
mitochondria-associated degradation (MAD) which in-
volves disposal of mitochondrial proteins - mainly from
the outer membrane - via a VCP/p97 and proteasome-
dependent pathway [19].
In addition, misfolded proteins in these compartments
trigger a compartment-specific unfolded protein response
(UPR) which aims to adjust the capacity of folding and
disposal in the organelle [20,21]. Sequestering of chap-
erones by misfolded proteins in the ER is rapidly sensed
by three sensor proteins: IRE1, PERK, and ATF6, and
launches the three-armed adaptive stress response of
the ER. While activation of PERK attenuates protein
translation thereby decreasing protein reloading of the
ER, IRE1 and ATF6 concertedly activate UPR-specific
transcription to increase the ER folding capacity and
function. When they fail, however, e.g., upon severe or
chronic ER stress, apoptosis is induced [22]. Accumula-
tion of misfolded proteins in the mitochondrial matrix
impairs the import of the transcription factor ATFS-1
into mitochondria but triggers its translocation to the
nucleus to induce expression of mitochondrial proteases
and chaperones [21]. A distinct mitochondrial unfolded
protein response exists also for the intermembrane
space [23]. Organelle proteostasis also involves bulk
degradation of whole organelles via the autophagy path-
way such as nucleophagy or mitophagy or by autophagic
disposal of parts of the dysfunctional ER [17,24].
Proteostasis in chronic lung diseases
Dysfunctional proteostasis is a common pathomechan-
ism for both, pediatric and adult, chronic lung diseases
that either are caused by inherited protein dysfunction
or involve sporadic impairment of protein homeostasis[2]. In this section, we will summarize available know-
ledge on proteostasis in the young and immature as well
as in the adult and aged lung.
Hereditary dysfunction of proteostasis
In the lung, the two major inherited genetic disorders,
cystic fibrosis and AAT deficiency, are conformational
disorders that are caused by the hereditary expression of
mutant alleles of the cystic fibrosis transmembrane con-
ductance regulator (CFTR) and AAT, respectively [25].
In addition, mutations of the surfactant proteins (SP) C,
B, and A have been identified in familial cases of IPF
[3,26]. All of these mutations pose a serious challenge
for the proteostasis network as they result not only in
impaired function of the respective protein but also in
ER stress, dysregulated proteasome, and altered autoph-
agy function [25-27]. The deltaF508CFTR mutant - the
most predominant CFTR mutation in cystic fibrosis pa-
tients - is characterized by a misfolded CFTR protein
which is rapidly degraded by the proteasome and thus
fails to translocate to the plasma membrane [28]. Conse-
quently, modulating the proteostasis network to stabilize
folding and trafficking of this CFTR mutant was suggested
as a beneficial therapeutic approach in CF [29]. Loss of
functional CFTR has further been associated with defect-
ive autophagy and accumulation of aggregated and polyu-
biquitinated proteins. Restoration of autophagy increased
CFTR trafficking to the cell membrane [15,30]. There is
also evidence for enhanced ER stress in CF patients as
summarized elsewhere [25], and inactivation of the XBP-1
pathway decreased inflammatory cytokine production in a
model of inflamed CF airway linking ER stress to inflam-
mation [31]. Likewise, in AAT deficiency, misfolded AAT
variants fail to exit the ER and are targeted for ERAD.
Some AAT variants polymerize and are degraded via au-
tophagy [25]. Thereby, misfolded AAT accumulates in
hepatocytes and cannot be secreted in the bloodstream,
which leads to unopposed protease activity in the lung
[30]. Activation of autophagy prevents aggregate toxicity
in hepatocytes and reversed liver pathology in a mouse
model of AAT deficiency [30]. Misfolded AAT primarily
leads to proteostasis imbalance and ER stress mainly in
the liver while the lung phenotype manifests later in life
due to unopposed protease activation [25]. However, as
aggregates of mutant AAT were also detected, e.g., in
alveolar macrophages, enhanced aggregate clearance
by autophagy might also be beneficial in the lung [30].
Similarly, most of the known mutations of the SP-C
and SP-A genes result in abnormal processing, folding,
and accumulation of the mutant protein in the ER,
possibly triggering ER stress in alveolar epithelial type
II cells (AECII). Subsequent induction of apoptosis in
the alveolar epithelium may then initiate fibrotic tissue
remodeling and chronic inflammatory responses
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proteasome and autophagy pathways has been shown
for some of the SP-C mutants in vitro [33]. The rare
hereditary disorder Hermansky-Pudlak syndrome is
also characterized by disturbed proteostasis, namely
impaired biogenesis of lysosome-related organelles, which
contributes to continuous damage and apoptosis of AECII
and early onset of pulmonary fibrosis [34].
Sporadic dysfunction of proteostasis
In addition to hereditary conformational disorders of
the lung, proteostasis is challenged by exposure of the
lung to noxious particles, chemicals, allergens, and patho-
gens which starts early in life and continues throughout
life, thereby contributing to age-related chronic lung
diseases [27,35].
Impaired proteostasis in the young and immature
lung Mechanical ventilation and oxygen supply are often
used as a treatment in preterm-born infants. While life-
saving, both, mechanical hyperinflation and hyperoxia,
damage the immature lung, thus contributing to devel-
opment of chronic lung diseases such as bronchopul-
monary dysplasia (BPD) which persists during childhood
and adulthood [36]. Among others, mechanical ventila-
tion and hyperoxia induce formation of reactive oxygen
species (ROS) which challenge the proteostasis network
of the immature lung due to oxidative protein modifica-
tions and protein folding stress [37,38]. Thus, exposure
of newborn mice to hyperoxia induced expression of ER
stress markers including CHOP that may contribute to
increased apoptosis [39]. Furthermore, hyperoxia altered
ER morphology and eIF2α phosphorylation but did not
affect other UPR pathways in a newborn rat model [40].
Whether mechanical ventilation and hyperoxia also trig-
ger autophagy or proteasome dysfunction in infants is
largely unknown. In adult mice lungs, however, autoph-
agy is increased upon mechanical ventilation and con-
tributes to cellular damage [41]. Furthermore, hyperoxia
induced autophagosome formation and expression of
autophagic proteins in bronchial epithelial cells and in
mice. Enhanced expression of the autophagic protein
LC3B-II decreased apoptosis in hyperoxia-treated cells
by regulating the extrinsic apoptosis pathway [42]. In
hyperoxia-treated adult mice, elevated levels of PINK1
helped to maintain mitochondrial homeostasis by indu-
cing autophagy of damaged mitochondria. In this study,
higher activity of the lung proteasome was observed as
well [43]. Hyperoxia also augmented ubiquitination and
expression of the chaperone HSP70 in bronchial epithe-
lial cells from adult patients treated with >95% oxygen
[44]. In contrast, HSP27 expression was decreased in
hyperoxia-treated newborn rats and in a human alveolar
epithelial cell line, A549 cells, while overexpression ofHSP27 in A549 cells attenuated hyperoxia-induced cell
death [45]. In summary, there is rising evidence for dys-
functional proteostasis in the ER and cytosol in response
to mechanical ventilation and/or hyperoxia in the adult
and also immature lung.
Asthma is the most common respiratory lung disease
in children affecting more than 10% of children between
2 and 15 years of age [46]. Recent studies support the
concept of asthma, although primarily an inflammatory
disease, as a disease initiated by recurrent dysfunction of
the airway epithelium which modulates inflammatory re-
sponses [47]. Accumulating evidence suggests a key role
for oxidative events and protein damage in the patho-
genesis of bronchial asthma [48,49]. Accordingly, ER
stress markers were found to be increased in blood cells
and bronchoalveolar lavage (BAL) from asthmatic pa-
tients and in the lung tissue of ovalbumin-challenged
mice. Furthermore, administration of chemical chaper-
ones reduced experimental asthma and inflammation in
mice [50]. This effect was mainly mediated by attenuating
ER stress-induced NFκB activation [50]. As NFκB activa-
tion can also be attenuated by inhibition of the prote-
asome, proteasome inhibitors have also been suggested as
potential therapeutics in asthma. However, although pro-
teasome inhibitors had some beneficial anti-inflammatory
effects, they were unable to ameliorate chronic asthma
in mice [16]. In addition, autophagy was shown to be
augmented in asthmatic patients: Expression of Atg5
was increased in nasal mucosal cells of children with
acute asthma and was associated with a single nucleo-
tide polymorphism (SNP) in the Atg5 promoter [51]. A
second SNP in the ATG5 gene was also associated with
the enhanced formation of autophagosomes [52]. Thus,
some initial evidence implicates an involvement of au-
tophagy in asthma, but the molecular mechanisms re-
main to be elucidated.
Another aspect of how impaired proteostasis may
affect development of asthma relates to the role of the
proteasome in MHC class I antigen presentation: As
the peptide products of proteasomal protein degradation
may be used for MHC class I antigen presentation, prote-
asome function is an essential part of the host response
towards intracellular infections by activating CD8+ T
cell-mediated adaptive immunity against viral infec-
tions [14]. Only one study has addressed the putative
involvement of the immunoproteasomes in asthma de-
velopment using knockout mice for the immunoprotea-
some subunit LMP7. LMP7-deficient animals mounted
a strong Th2 response during ovalbumin-induced but
not house dust mite-induced acute asthma [53]. The role
of immunoproteasome-dependent immune responses to
virus infection in asthma has not been investigated so far.
In general, the contribution of proteostasis systems to
sporadic lung disease in infants and children is only
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protein homeostasis is dysregulated in the development of
BPD and asthma. However, to what extent the different
proteostasis pathways contribute to these pediatric dis-
eases, how they interact or compensate for each other,
and whether they represent a feasible therapeutic target
await further investigation.
Deficient proteostasis in the adult and aged lung Im-
paired proteostasis has been identified as a key and com-
mon pathomechanism for sporadic chronic lung diseases
as reviewed extensively elsewhere [2,15,16,30]. Thus, we
will only briefly outline the basic findings and would like
to refer the reader to the details as given in the above
cited reviews.
For sporadic chronic lung diseases in the adult, cigarette
smoke remains the main risk factor. As such, cigarette
smoke exposure of the lung represents a paradigm for en-
vironmental insults that drive pathogenesis of chronic
lung diseases. Among the more than 4,700 chemicals of
cigarette smoke, reactive compounds oxidatively modify
cellular proteins, thereby seriously challenging the pro-
teostasis network of the cell. Several proteins such as
secretory proteins, histone-modifying enzymes, signaling
mediators, and transcriptional regulators have been shown
to be oxidatively modified by cigarette smoke, adding to
cellular dysfunction and pathogenesis of chronic lung dis-
eases [54,55]. In agreement with the increased burden of
misfolded proteins, e.g., upon cigarette smoke exposure,
protein quality control pathways are mainly activated in
adult chronic lung diseases. Induction of autophagy is a
prominent feature in the lungs of patients with COPD as
well as in mice chronically exposed to cigarette smoke
[56]. Autophagy is also increased in PAH tissue, and mice
lacking the autophagic protein LC3B showed exaggerated
features of PAH in a hyperoxia model [30,57]. These find-
ings together with the observation of fragmented mito-
chondrial morphology in pulmonary smooth muscle cells
of PAH patients raised some speculation on a pathogen-
etic contribution of mitophagy in PAH [58]. However, ac-
tivation of mitophagy in PAH could not be confirmed
experimentally. Conflicting data also exist for the role of
mitochondrial quality control in COPD. In IPF, autophagy
pathways are not activated but rather impaired [59]. A re-
cent study as well as unpublished data from our lab sug-
gests that proteostasis in IPF might be rather regulated on
the level of 26S proteasome activation [3,60]. For COPD,
conflicting data exist on proteasome function in the lung:
While Malhotra et al. observed a decline in proteasome
expression and activity in the lungs of COPD patients
which correlated with progressive disease severity [61],
Baker et al. did not observe any decline in proteasome ac-
tivity in end-stage COPD tissue [60]. Induction of ER
stress in the lung has been observed in response tocigarette smoke exposure as well as in pulmonary fibrosis
[62]. In transgenic mouse models, induction of ER stress
in the alveolar epithelium predisposes to enhanced lung fi-
brosis after treatment with bleomycin [26]. Furthermore,
ER stress markers are observed in pulmonary hyperten-
sion, and treatment of rats with the modulator of the un-
folded protein response salubrinal attenuated experimental
PAH [63].
Protein quality control pathways are not only activated
as an adaptive response to altered proteostasis, but they
may also be direct targets of noxious environmental ex-
posures as recently shown for the proteasome. Acute ex-
posure to cigarette smoke directly inhibits the catalytic
activity of purified proteasomes and proteasome activity
of bronchial and alveolar epithelial cells as well as in mouse
lungs [64,65]. Oxidative impairment of the ER-resident
protein disulfide isomerase by cigarette smoke also expands
protein misfolding in the ER compartment [54]. Such im-
pairment of protein quality control further exacerbates the
detrimental effects of noxious exposures of the lung and
may amplify progression of chronic lung diseases. In line
with this notion, proteostasis has been shown to decline
with aging [66]. As a consequence of aging, misfolded pro-
teins accumulate over time and proteostasis pathways
become functionally impaired in response to persistent or
repeated environmental exposures, thereby amplifying
protein damage [6]. Age-related impairment of proteosta-
sis has been observed on all levels including diminished
chaperone availability, altered autophagy regulation, im-
paired proteasome function, and activation of unfolded
protein responses in the ER and mitochondria [66-68]. Of
note, only very few studies analyzed the impact of an aged
proteostasis network on the development or progression
of chronic respiratory diseases using animal models [69].
Further research will be required to delineate the contri-
bution of single proteostasis pathways to distinct age-
related chronic lung diseases.
Conclusions
Dysregulation of proteostasis is an emerging common
pathomechanism for chronic lung diseases in the adult
and aged patient. There is also rising evidence that sporadic
impairment of protein homeostasis contributes to early
disease onset in pediatric lung disorders beyond the well-
known hereditary proteostasis disorders such as cystic
fibrosis and AAT deficiency. Maintaining protein homeo-
stasis in the lung is particularly relevant in any condition
that leads to sustained generation of ROS, e.g., mechanical
ventilation, hyperoxia, and exposure to noxious particles
and gases. In particular, compartment-specific dysregula-
tion of proteostasis such as the unfolded protein response
of the ER and mitochondria and altered proteasome
function are emerging as novel aspects of dysregulated
proteostasis in the diseased lung. The interplay of the
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such as cilia and vesicle transport is only beginning to be
unraveled [3]. In particular, the close interaction of protein
homeostasis with immune response pathways is a largely
neglected aspect of how impaired proteostasis within a
single cell outreaches its neighborhood: Proteasome func-
tion is essential for MHC class I-mediated adaptive im-
munity against viral and intracellular infections [14]. In
addition, autophagy is central for innate immune surveil-
lance of pathogens and also affects MHC class II presenta-
tion [70]. Moreover, proper function of the ER is required
to ensure expression of immune relevant surface mole-
cules and secretion of cytokines [71].
This adds a novel aspect to the concept of modulating
proteostasis for disease intervention as proposed by
Bouchecareilh and Balch [27] and may stimulate further
research on dysregulated proteostasis in the young and
adult lung.
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